Edmond de Rothschild Investment Partners (EdRIP) gave a progress report on the raising of its BioDiscovery 4 fund as the investment group celebrated its 10th anniversary and set out plans to raise €500 million (US$677 million) for life sciences venture capital and growth capital for small- and mid-cap companies across all sectors, by 2016.